Diverse Role of blaCTX-M and Porins in Mediating Ertapenem Resistance among Carbapenem-Resistant Enterobacterales

Cody A. Black,Raymond Benavides,Sarah M. Bandy,Steven D. Dallas,Gerard Gawrys,Wonhee So,Alvaro G. Moreira,Samantha Aguilar,Kevin Quidilla,Dan F. Smelter,Kelly R. Reveles,Christopher R. Frei,Jim M. Koeller,Grace C. Lee

DOI: https://doi.org/10.3390/antibiotics13020185

2024-02-14

Antibiotics

Abstract:Among carbapenem-resistant Enterobacterales (CRE) are diverse mechanisms, including those that are resistant to meropenem but susceptible to ertapenem, adding further complexity to the clinical landscape. This study investigates the emergence of ertapenem-resistant, meropenem-susceptible (ErMs) Escherichia coli and Klebsiella pneumoniae CRE across five hospitals in San Antonio, Texas, USA, from 2012 to 2018. The majority of the CRE isolates were non-carbapenemase producers (NCP; 54%; 41/76); 56% of all NCP isolates had an ErMs phenotype. Among ErMs strains, E. coli comprised the majority (72%). ErMs strains carrying blaCTX-M had, on average, 9-fold higher copies of blaCTX-M than CP-ErMs strains as well as approximately 4-fold more copies than blaCTX-M-positive but ertapenem- and meropenem-susceptible (EsMs) strains (3.7 vs. 0.9, p < 0.001). Notably, carbapenem hydrolysis was observed to be mediated by strains harboring blaCTX-M with and without a carbapenemase(s). ErMs also carried more mobile genetic elements, particularly IS26 composite transposons, than EsMs (37 vs. 0.2, p < 0.0001). MGE- ISVsa5 was uniquely more abundant in ErMs than either EsMs or ErMr strains, with over 30 more average ISVsa5 counts than both phenotype groups (p < 0.0001). Immunoblot analysis demonstrated the absence of OmpC expression in NCP-ErMs E. coli, with 92% of strains lacking full contig coverage of ompC. Overall, our findings characterize both collaborative and independent efforts between blaCTX-M and OmpC in ErMs strains, indicating the need to reappraise the term "non-carbapenemase (NCP)", particularly for strains highly expressing blaCTX-M. To improve outcomes for CRE-infected patients, future efforts should focus on mechanisms underlying the emerging ErMs subphenotype of CRE strains to develop technologies for its rapid detection and provide targeted therapeutic strategies.

pharmacology & pharmacy,infectious diseases

What problem does this paper attempt to address?

The paper aims to explore the diverse roles of blaCTX-M and porins in mediating ertapenem resistance in Enterobacterales that are resistant to ertapenem but sensitive to meropenem (ErMs). Specifically:

1. **Research Background**: The research background indicates that although carbapenem antibiotics are the last line of defense against multi-drug resistant infections, Enterobacterales have developed various mechanisms to resist these antibiotics. Particularly, the resistance mechanisms of strains that do not produce carbapenemase (NCP) are not yet fully understood.

2. **Research Subjects**: The study focuses on samples of ertapenem-resistant but meropenem-sensitive Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae) collected from five hospitals in San Antonio, Texas, between 2012 and 2018.

3. **Main Findings**:
- The study found that non-carbapenemase-producing (NCP) strains constituted the majority (54%) of these samples, and 56% of them exhibited the ErMs phenotype.
- E. coli accounted for the majority (72%) of the ErMs strains.
- The copy number of the blaCTX-M gene in ErMs strains was approximately 9 times higher than in CP-ErMs strains and about 4 times higher than in blaCTX-M positive but both ertapenem and meropenem sensitive (EsMs) strains.
- Porin OmpC expression was absent in NCP-ErMs E. coli, with 92% of the strains lacking complete ompC sequence coverage.

4. **Conclusion**: The study results suggest that blaCTX-M and porin OmpC have both synergistic and independent roles in ErMs strains, indicating a need to reassess the term "non-carbapenemase-producing (NCP)," especially for strains with high blaCTX-M expression. Future research should focus on the mechanisms of the ErMs sub-phenotype to develop rapid detection techniques and provide targeted treatment strategies to improve the treatment outcomes for patients with CRE infections.